These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23465677)

  • 1. Esophagectomy after chemoradiation: who and when to operate.
    Kim JY; Hofstetter WL
    Semin Thorac Cardiovasc Surg; 2012; 24(4):288-93. PubMed ID: 23465677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the optimal interval between chemoradiation and esophagectomy?
    Martin LW
    Semin Thorac Cardiovasc Surg; 2012; 24(2):87-9. PubMed ID: 22920522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.
    Semenkovich TR; Panni RZ; Hudson JL; Thomas T; Elmore LC; Chang SH; Meyers BF; Kozower BD; Puri V
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2221-2230.e1. PubMed ID: 29428700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?
    Hsu PK; Chien LI; Huang CS; Hsieh CC; Wu YC; Hsu WH; Chou TY
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):460-6. PubMed ID: 23728085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thoracic versus cervical anastomosis on anastomotic leak among patients who undergo esophagectomy after neoadjuvant chemoradiation.
    Chidi AP; Etchill EW; Ha JS; Bush EL; Yang SC; Battafarano RJ; Broderick SR
    J Thorac Cardiovasc Surg; 2020 Oct; 160(4):1088-1095. PubMed ID: 32299695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.
    Spector R; Zheng Y; Yeap BY; Wee JO; Lebenthal A; Swanson SJ; Marchosky DE; Enzinger PC; Mamon HJ; Lerut A; Odze R; Srivastava A; Agoston AT; Tippayawang M; Bueno R;
    Semin Thorac Cardiovasc Surg; 2015; 27(2):205-15. PubMed ID: 26686448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive or neoadjuvant chemoradiotherapy for squamous cell oesophageal cancer?
    Ilson D; Lordick F
    Lancet Oncol; 2018 Oct; 19(10):1285-1286. PubMed ID: 30528077
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer.
    Sihag S; Ku GY; Tan KS; Nussenzweig S; Wu A; Janjigian YY; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):836-843.e1. PubMed ID: 33485662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.
    Blum Murphy MA; Elimova E; Ajani JA
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):383-92. PubMed ID: 26560689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
    Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
    Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
    J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival.
    Samson P; Puri V; Lockhart AC; Robinson C; Broderick S; Patterson GA; Meyers B; Crabtree T
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1725-1735. PubMed ID: 30054137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Disease Recurrence and Survival in Esophageal Adenocarcinomas With Complete Response to Neoadjuvant Therapy.
    Agoston AT; Zheng Y; Bueno R; Lauwers GY; Odze RD; Srivastava A
    Am J Surg Pathol; 2015 Aug; 39(8):1085-92. PubMed ID: 26076061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma.
    Chen HS; Hsu PK; Liu CC; Wu SC
    Sci Rep; 2018 Feb; 8(1):2180. PubMed ID: 29391589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.
    Sohda M; Miyazaki T; Sakai M; Kumakura Y; Honjyo H; Hara K; Tanaka N; Yokobori T; Shirabe K
    Anticancer Res; 2019 Jun; 39(6):3167-3175. PubMed ID: 31177163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Saeki H; Nakashima Y; Zaitsu Y; Tsuda Y; Kasagi Y; Ando K; Imamura Y; Ohgaki K; Ito S; Kimura Y; Egashira A; Oki E; Morita M; Maehara Y
    Surg Today; 2016 Mar; 46(3):261-7. PubMed ID: 25740123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal nightmare: cancer recurrence after definitive chemoradiation. Is salvage esophagectomy possible?
    Rice TW
    Semin Thorac Cardiovasc Surg; 2013; 25(2):83-6. PubMed ID: 24216522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer.
    Bagheri R; RajabiMashhadi MT; Ghazvini K; Asnaashari A; Zahediyan A; Sahebi MA
    Interact Cardiovasc Thorac Surg; 2012 Jun; 14(6):725-8. PubMed ID: 22392934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Combination of Respiratory Comorbidity and Neoadjuvant Chemoradiotherapy May Double the Risk of Anastomotic Leaks After Esophagectomy: Do We Know Enough to Tailor Neoadjuvant Therapies, or Take Other Preemptive Measures in High-Risk Patients?
    Nilsson M
    Ann Surg Oncol; 2019 Sep; 26(9):2660-2661. PubMed ID: 31228133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.